Global $12.03 Bn Digital Diabetes Market 2019-2025: Increase in Penetration of Smartphone & Advance Device-Agonistic Feature

News provided by

Mar 22, 2019, 12:15 ET

DUBLIN, March 22, 2019 /PRNewswire/ -- The "Digital Diabetes Market by Product (SMBG, CGM, Smart Insulin Pump, Smart Insulin Pens, Software, Apps), End User (Home Care, Hospitals and Clinics), and Geography - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global digital diabetes market is expected to grow at a CAGR of 21.7% from 2018 to reach $12.03 billion by 2025. A rising number of diabetic patients, increasing penetration of smartphones, technological advancement in diabetes devices, and growing funding for diabetes are the key factors driving the growth of this market. However, the high cost of devices and poor reimbursement scenario is expected to hinder the growth of this market in the coming years.

Devices dominated the global digital diabetes market in 2018. With the growing diabetic population, increasing adoption of diabetes devices, and increasing awareness about diabetes in emerging countries, this market is also expected to continue its dominance in the near future. Devices market is segmented into Self-Monitoring Blood Glucose (SMBG) systems, Continuous Glucose Monitoring (CGM) systems, insulin pumps, and insulin pens. CGM systems accounted for the largest share of digital diabetes devices market, by type. Increasing adoption of CGM systems, development of advanced CGM systems, and favorable government policies in developed countries are the key factors driving the growth of this segment.

Diabetes management apps are expected to grow at the highest CAGR during the forecast period. The high growth of this segment is mainly attributed to increasing penetration of smartphones, growing awareness about diabetes management apps, and increasing funding for diabetes management apps.

Key Topics Covered:

1. Introduction
1.1. Market Definition
1.2. Market Segmentation
1.3. Currency
1.4. Limitations
1.5. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation

3. Executive Summary
3.1. Introduction
3.2. Market Dynamics
3.3. Product Segment Analysis
3.4. End User Segment Analysis
3.5. Regional Analysis
3.6. Competitive Analysis

4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Rising Number of Diabetic Patients
4.2.2. Increase Funding for Software and Apps
4.2.3. Growing Popularity of Bundles
4.2.4. Increase in Penetration of Smartphone & Advance Device-Agonistic Feature
4.3. Restraints
4.3.1. High Cost of Devices and Lack of Proper Reimbursement
4.4. Opportunities
4.4.1. Pipeline Products
4.4.2. High Growth in Emerging Countries

5. Industry Analysis
5.1. Diabetes Statistics
5.2. Evolution of Diabetes Management
5.3. Technology Evolution/Overview

6. Global Digital Diabetes Market, by Product
6.1. Introduction
6.2. Diabetes Management Devices
6.2.1. Smart Insulin Pumps
6.2.1.1.Traditional Insulin Pumps
6.2.1.2.Tubeless/Patch Pumps
6.2.1.3.Threshold Suspend Device System & Close Loop Pumps
6.2.2. Continuous Glucose Monitoring (CGM) Systems
6.2.3. SMBG Systems
6.2.4. Smart Insulin Pens
6.3. Diabetes Management Software
6.4. Diabetes Management Apps

7. Global Digital Diabetes Market, by End User
7.1. Introduction
7.2. Hospitals and Clinics
7.3. Homecare

8. Digital Diabetes Market, by Geography
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. U.K.
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. Rest of APAC
8.5. Latin America
8.6. Middle East & Africa

9. Competitive Landscape
9.1. Introduction
9.2. Market Share Analysis
9.3. Competitive Situations and Trends
9.3.1. Approvals
9.3.2. Agreement and Collaborations
9.3.3. Acquisitions
9.3.4. Product Launch
9.3.5. Other Developments

10. Company Profiles (Business Overview, Financial Overview, Product & Service Portfolio, Strategic Developments)
10.1. LifeScan, Inc.
10.2. Roche AG
10.3. Medtronic
10.4. Ascensia Diabetes Care.
10.5. Tandem Diabetes Care, Inc.
10.6. Dexcom, Inc.
10.7. SocialDiabetes
10.8. One Drop.
10.9. H2 Inc.
10.10. Dottli
10.11. Abbott Laboratories
10.12. Ypsomed Holding AG
10.13. ARKRAY, Inc.
10.14. Insulet Corporation
10.15. ACON Laboratories, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/rrtsqd/global_12_03_bn?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets